Private Market View

Baojuhe Medical

Suzhou, China · Founded 2023 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Sinovation Ventures.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for Baojuhe Medical
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Baojuhe Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Baojuhe Medical

Developer of a medical device platform designed to advance the research and development of self-medication technologies for healthcare and wellness. The company offers integrated device engineering, clinical-stage instrumentation, and end-to-end development capabilities, enabling pharmaceutical companies and healthcare providers to streamline drug delivery and enhance patient independence.

Sector
Healthcare
HQ
Suzhou, China
Founded
2023
Ownership
Privately Held (backing)
PA Mark — not yet priced

Baojuhe Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Baojuhe Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Baojuhe Medical in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.